PERSPECTA

News from every angle

Back to headlines

Grail's $950 Multi-Cancer Blood Test Available Despite Lack of FDA Approval

Grail's $950 multi-cancer blood test is now available for purchase via telemedicine, though it has not yet received FDA approval.

30 May, 13:13 — 30 May, 13:13
PostShare